Pulmonary embolism in a healthy woman using the oral contrac
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Abstract :
Venous thromboembolism is well known as one of the rare but serious adverse effects of combined oral contraceptives (COCs). The COCs with third and fourth generation progestogens were found to have higher risk of venous thrombosis than those with second generation progestogens. We present a case of pulmonary embolism in a 23-year-old nulligravid woman who was using COCs containing the third generation progestogen (desogestrel). At the time of presentation of the adverse effect, she had been using the COCs for 4 months. She had no additional risk factors for thrombosis such as smoking, surgery, tumor as well as genetic factors. This case demonstrates even young women in otherwise good health may be at risk of venous thromboembolism from low-dose formulations of COCs as an over-the-counter drug. We describe this case with a brief review of literatures.....

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364109/
Dr. J●●●●●●●h K●●●●●●n and 4 others like this
Like
Comment
Share
Dr. A●●n G●●●i
Dr. A●●n G●●●i Obstetrics and Gynaecology
Only for 4 months use of coc ' s without any medical risk factors this type of compilation is very rare .
Apr 23, 2017Like